Fear of cancer may have unwanted effect on public screening uptake
the ONA take:
People who worry about developing cancer are more likely to want to undergo screening for colon cancer; however, according to new research from the Cancer Research UK Health Behaviour Research Centre at UCL, that fear makes them less likely to actually go for the test.
Research to date has used a combined measure of cancer fear, which does not explain how fear results in such different actions. In this study, the researchers distinguished different aspects of fear to see whether it had different effects on people’s decisions about cancer screening.
Approximately 2,000 participants were randomized to receive a screening invitation. Clinical records show that 71% actually attended; 68% of those who reported feeling uncomfortable thinking about cancer attended screening, compared with 77% of those who did not feel uncomfortable.
The research findings suggest that public service announcements about colon cancer screening need to focus more on the preventive value of screening than increasing public fear of cancer.
People who worry about developing cancer are more likely to want to undergo screening for colon cancer.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- No Difference Between RA Seed Localization and Wire Guided Localization
- BRD4 Inhibitor May Enhance Sensitivity to Endocrine Therapies
- Dual HER2 Blockade With an AI Effective in Advanced Breast Cancer
- Loperamide Regimen May Reduce Diarrhea in Neratinib-treated Patients
- PAM50 HER2-E Subtype Predicts pCR Following Lapatinib, Trastuzumab
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|